NovoCure (NVCR) Enterprise Value Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.50% |
| Dec 31, 2025 | 89.23% |
| Sep 30, 2025 | 64.10% |
| Jun 30, 2025 | 9.68% |
| Mar 31, 2025 | -6.78% |
| Dec 31, 2024 | -5.41% |
| Sep 30, 2024 | -4.20% |
| Jun 30, 2024 | -6.95% |
| Mar 31, 2024 | -366.22% |
| Dec 31, 2023 | 6.07% |
| Sep 30, 2023 | -277.50% |
| Jun 30, 2023 | 83.40% |
| Mar 31, 2023 | 2.60% |
| Dec 31, 2022 | -3.38% |
| Sep 30, 2022 | 73.87% |
| Jun 30, 2022 | -163.05% |
| Mar 31, 2022 | 77.83% |
| Dec 31, 2021 | -11.29% |
| Sep 30, 2021 | -296.71% |
| Jun 30, 2021 | -4.00% |
| Mar 31, 2021 | -373.11% |
| Dec 31, 2020 | -369.62% |
| Sep 30, 2020 | -12.00% |
| Jun 30, 2020 | -21.83% |
| Mar 31, 2020 | 28.80% |
| Dec 31, 2019 | -25.68% |
| Sep 30, 2019 | 7.70% |
| Jun 30, 2019 | -29.97% |
| Mar 31, 2019 | -125.56% |
| Dec 31, 2018 | -76.86% |
| Sep 30, 2018 | -22.05% |
| Jun 30, 2018 | -18.75% |
| Mar 31, 2018 | 39.89% |
| Dec 31, 2017 | 63.25% |
| Sep 30, 2017 | 20.80% |
| Jun 30, 2017 | 8.20% |
| Mar 31, 2017 | 19.73% |
| Dec 31, 2016 | 18.48% |
| Sep 30, 2016 | -71.53% |
| Jun 30, 2016 | -88.58% |
| Mar 31, 2016 | -217.68% |
| Dec 31, 2015 | -162.57% |
| Sep 30, 2015 | -71.70% |